Northern Trust
ZURA icon

Northern Trust’s Zura Bio ZURA Stock Holding History

Northern Trust’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$620K Buy
104,130
+3,294
+3% +$19.9K ﹤0.01% 3527
2025
Q4 		$528K Buy
100,836
+14,399
+17% +$56.9K ﹤0.01% 3636
2025
Q3 		$374K Sell
86,437
-7,724
-8% -$13.9K ﹤0.01% 3755
2025
Q2 		$98.9K Sell
94,161
-275,197
-75% -$329K ﹤0.01% 4114
2025
Q1 		$476K Sell
369,358
-32,636
-8% -$51.5K ﹤0.01% 3590
2024
Q4 		$1M Buy
401,994
+57,583
+17% +$205K ﹤0.01% 3391
2024
Q3 		$1.4M Buy
344,411
+171,558
+99% +$641K ﹤0.01% 3198
2024
Q2 		$605K Buy
172,853
+136
+0.1% +$554 ﹤0.01% 3438
2024
Q1 		$444K Buy
172,717
+2,540
+1% +$9K ﹤0.01% 3596
2023
Q4 		$795K Buy
170,177
+73,995
+77% +$370K ﹤0.01% 3388
2023
Q3 		$635K Buy
96,182
+26,319
+38% +$176K ﹤0.01% 3447
2023
Q2 		$573K Buy
+69,863
New +$561K ﹤0.01% 3508

Other funds holding ZURA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Northern Trust's ZURA Position: Q1 2026 in Review

Northern Trust increased its Zura Bio (ZURA) stake by 3.3% in Q1 2026, buying an estimated $19.9K and bringing the position to 104,130 shares worth $620K. The position accounts for ﹤0.01% of the portfolio, ranked #3527.

Northern Trust first reported a position in ZURA in Q2 2023 and has held it in 12 quarters since. The position peaked at $1.4M in Q3 2024. 94 funds tracked by Wall St. Rank hold ZURA as of Q1 2026.

  • Northern Trust held 104,130 shares of Zura Bio worth $620K as of Q1 2026.
  • Northern Trust bought 3,294 Zura Bio shares in Q1 2026, an estimated $19.9K.
  • Zura Bio made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #3527 holding.
  • Northern Trust first reported a position in Zura Bio in Q2 2023 and has held it in 12 quarters since.
  • Northern Trust's Zura Bio position peaked at $1.4M in Q3 2024.
  • 94 funds tracked by Wall St. Rank held Zura Bio as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.